A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 17,741 shares of IONS stock, worth $656,594. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17,741
Previous 44,256 59.91%
Holding current value
$656,594
Previous $2.11 Million 66.33%
% of portfolio
0.0%
Previous 0.01%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$40.06 - $51.86 $1.06 Million - $1.38 Million
-26,515 Reduced 59.91%
17,741 $710,000
Q2 2024

Aug 09, 2024

BUY
$36.45 - $47.7 $1.61 Million - $2.11 Million
44,256 New
44,256 $2.11 Million
Q4 2023

Feb 09, 2024

SELL
$43.39 - $51.63 $80,618 - $95,928
-1,858 Reduced 1.43%
127,954 $6.47 Million
Q3 2023

Nov 13, 2023

SELL
$38.5 - $47.13 $2.64 Million - $3.24 Million
-68,696 Reduced 34.61%
129,812 $5.89 Million
Q2 2023

Aug 10, 2023

SELL
$34.73 - $43.33 $2.79 Million - $3.48 Million
-80,250 Reduced 28.79%
198,508 $8.14 Million
Q1 2023

May 09, 2023

BUY
$33.58 - $41.2 $1.62 Million - $1.99 Million
48,181 Added 20.9%
278,758 $9.96 Million
Q4 2022

Feb 10, 2023

BUY
$37.12 - $46.52 $56,273 - $70,524
1,516 Added 0.66%
230,577 $8.71 Million
Q3 2022

Nov 10, 2022

BUY
$36.54 - $48.66 $3.55 Million - $4.72 Million
97,078 Added 73.55%
229,061 $10.1 Million
Q2 2022

Aug 05, 2022

SELL
$31.71 - $43.0 $799,409 - $1.08 Million
-25,210 Reduced 16.04%
131,983 $4.89 Million
Q1 2022

May 12, 2022

BUY
$29.88 - $37.04 $1.33 Million - $1.65 Million
44,668 Added 39.7%
157,193 $5.82 Million
Q4 2021

Feb 10, 2022

BUY
$25.61 - $35.1 $1.97 Million - $2.7 Million
76,989 Added 216.65%
112,525 $3.42 Million
Q3 2021

Nov 12, 2021

BUY
$33.54 - $40.55 $1.19 Million - $1.44 Million
35,536 New
35,536 $1.19 Million
Q2 2021

Aug 12, 2021

SELL
$34.54 - $47.25 $1.78 Million - $2.44 Million
-51,579 Closed
0 $0
Q1 2021

May 13, 2021

BUY
$42.51 - $63.78 $2.19 Million - $3.29 Million
51,579 New
51,579 $2.32 Million
Q4 2019

Feb 12, 2020

SELL
$53.85 - $65.27 $1.01 Million - $1.23 Million
-18,825 Closed
0 $0
Q3 2019

Nov 13, 2019

BUY
$59.06 - $72.15 $1.11 Million - $1.36 Million
18,825 New
18,825 $1.13 Million
Q3 2018

Nov 13, 2018

SELL
$42.88 - $53.7 $1.25 Million - $1.57 Million
-29,150 Closed
0 $0
Q2 2018

Aug 02, 2018

BUY
$40.53 - $50.7 $1.18 Million - $1.48 Million
29,150 New
29,150 $1.22 Million

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.25B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Connor, Clark & Lunn Investment Management Ltd. Portfolio

Follow Connor, Clark & Lunn Investment Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.